Clinical impact of 18F-FDG-PET/CT in the extra cardiac work-up of patients with infective endocarditis

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 9, 2014, Pages 1013-1019

  Asmar, Ali ^a   Özcan, Cengiz ^a   Diederichsen, Axel C P ^a   Thomassen, Anders ^a   Gill, Sabine ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

18F FDG PET CT; Clinical impact; Extra cardiac work up; Infective endocarditis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; ENDOCARDITIS; FEMALE; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; SCINTISCANNING;

COMORBIDITY; ENDOCARDITIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84906888322     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu054     Document Type: Article

References (35)

1. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009;30:2369-413.
2. WilsonW, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council onClinical Cardiology, Councilon Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116:1736-54.
3. Mylonakis E, Calderwood SB. Infective endocarditis in adults.NEngl J Med 2001;345: 1318-30.
4. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: changing epidemiology and predictors of 6-month mortality: a prospective cohort study. Eur Heart J 2007;28:196-203.
5. Di SG, Habib G, Pergola V, Avierinos JF, Philip E, Casalta JP et al. Echocardiography predicts embolic events in infective endocarditis. JAmColl Cardiol 2001;37:1069-76.
6. Tornos P, Iung B, Permanyer-Miralda G, Baron G, Delahaye F, Gohlke-Barwolf C et al. Infective endocarditis in Europe: lessons from the Euro heart survey. Heart 2005;91: 571-5.
7. Bleeker-Rovers CP, de Kleijn EM, Corstens FH, van der Meer JW, Oyen WJ. Clinical value of FDG PET in patients with fever of unknown origin and patients suspected of focal infection or inflammation. Eur J Nucl Med Mol Imaging 2004;31:29-37.
8. Manohar K, Mittal BR, Jain S, Sharma A, Kalra N, Bhattacharya A et al. F-18 FDG-PET/ CTin evaluation of patients with fever of unknown origin. Jpn J Radiol 2013;31:320-7.
9. Balink H, Verberne HJ, Bennink RJ, van Eck-Smit BL. A rationale for the use of F18-FDG PET/CT in fever and inflammation of unknown origin. Int J Mol Imaging 2012;2012:165080.
10. Crouzet J, Boudousq V, Lechiche C, Pouget JP, Kotzki PO, Collombier L et al. Place of (18)F-FDG-PET with computed tomography in the diagnostic algorithm of patients with fever of unknown origin. Eur J Clin Microbiol Infect Dis 2012;31:1727-33.
11. Ozcan C, Asmar A, Gill S, Thomassen A, Diederichsen AC. The value of FDG-PET/CT in the diagnostic work-up of extra cardiac infectious manifestations in infectious endocarditis. Int J Cardiovasc Imaging 2013;29:1629-37.
12. Prendergast BD. The changing face of infective endocarditis. Heart 2006;92:879-85.
13. Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J 2011;32:2027-33.
14. Thuny F, Di SG, Belliard O, Avierinos JF, Pergola V, Rosenberg V et al. Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study. Circulation 2005;112:69-75.
15. Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol 2001;2:157-64.
16. Bruun NE, Habib G, Thuny F, Sogaard P. Cardiac imaging in infectious endocarditis. Eur Heart J 2014;35:624-30.
17. Hayempour BJ, Alavi A. Neuroradiological advances detect abnormal neuroanatomy underlying neuropsychological impairments: the power of PET imaging. Eur J Nucl Med Mol Imaging 2013;40:1462-8.
18. Termaat MF, Raijmakers PG, Scholten HJ, Bakker FC, Patka P, Haarman HJ. The accuracyof diagnostic imaging for the assessment of chronic osteomyelitis: a systematic review and meta-analysis. J Bone Joint Surg Am 2005;87:2464-71.
19. el Esper I, Dacquet V, Paillard J, Bascoulergue G, Tahon MM, Fonroget J. 99Tcm-HMPAO-labelled leucocyte scintigraphy in suspected chronic osteomyelitis related to an orthopaedic device: clinical usefulness. Nucl Med Commun 1992;13: 799-805.
20. van der BW, Bleeker-Rovers CP, Boerman OC, Gotthardt M, Oyen WJ. PET and SPECT in osteomyelitis and prosthetic bone and joint infections: a systematic review. Semin Nucl Med 2010;40:3-15.
21. Hartmann A, Eid K, Dora C, Trentz O, von Schulthess GK, Stumpe KD. Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis. Eur J Nucl Med Mol Imaging 2007;34:704-14.
22. Prandini N, Lazzeri E, Rossi B, Erba P, Parisella MG, Signore A. Nuclear medicine imaging of bone infections. Nucl Med Commun 2006;27:633-44.
23. Robiller FC, Stumpe KD, Kossmann T, Weisshaupt D, Bruder E, von Schulthess GK. Chronic osteomyelitis of the femur: value of PET imaging. Eur Radiol 2000;10:855-8.
24. Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998;206:749-54.
25. Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L et al. Fluorine-18-FDG PET and technetium-99 m antigranulocyte antibody scintigraphy in chronic osteomyelitis. J Nucl Med 1998;39:2145-52.
26. de WF, van de WC, Vogelaers D, de SK, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am 2001;83-A:651-60.
27. Chacko TK, Zhuang H, Nakhoda KZ, Moussavian B, Alavi A. Applications of fluorodeoxyglucose positron emission tomography in the diagnosis of infection. Nucl Med Commun 2003;24:615-24.
28. Kaim A, Ledermann HP, Bongartz G, Messmer P, Muller-Brand J, Steinbrich W. Chronic post-traumatic osteomyelitis of the lower extremity: comparison of magnetic resonance imaging and combined bone scintigraphy/immunoscintigraphy with radiolabelled monoclonal antigranulocyte antibodies. Skeletal Radiol 2000;29:378-86.
29. Fukuchi K, Ishida Y, Higashi M, Tsunekawa T, Ogino H, Minatoya K et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg 2005;42:919-25.
30. Bonfiglioli R, Nanni C, Morigi JJ, Graziosi M, Trapani F, BartolettiMet al. (1)(8)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. Eur J Nucl Med Mol Imaging 2013;40:1190-6.
31. Saby L, Laas O, Habib G, Cammilleri S, Mancini J, Tessonnier L et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. J Am Coll Cardiol 2013;61:2374-82.
32. Jensen AG. Importance of focus identification in the treatment of Staphylococcus aureus bacteraemia. J Hosp Infect 2002;52:29-36.
33. Bleeker-Rovers CP, Vos FJ, Wanten GJ, van der Meer JW, Corstens FH, Kullberg BJ et al. 18F-FDG PET in detecting metastatic infectious disease. J Nucl Med 2005;46: 2014-9.
34. Vos FJ, Bleeker-Rovers CP, Kullberg BJ, Adang EM, Oyen WJ. Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia. J Nucl Med 2011;52:1673-8.
35. Van RJ, Hill EE, Gheysens O, Dymarkowski S, Herregods MC, Herijgers P et al. (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis. Eur J Nucl Med Mol Imaging 2010;37:1189-97.